Insider Trading & Ownership - Pontifax Late Stage GP Ltd.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Pontifax Late Stage GP Ltd.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-11-17
Purchase
2020-11-19
4:40 pm
Keros Therapeutics Inc.KROSNussbaum Ran
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
Director
10% Owner
60,000$50$3,000,000155,262
(Indirect)
View
2020-11-17
Purchase
2020-11-19
4:39 pm
Keros Therapeutics Inc.KROSKariv Tomer
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
Director
10% Owner
60,000$50$3,000,000155,262
(Indirect)
View
2020-11-17
Purchase
2020-11-19
4:38 pm
Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
60,000$50$3,000,000155,262
(Indirect)
View
2020-04-13
Purchase
2020-04-13
5:18 pm
Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
437,499$16$6,999,984149,262
(Indirect)
View
2019-11-11
Purchase
2019-11-13
7:10 pm
89bio Inc.ETNBKariv Tomer
Pontifax (Israel) V L.P.
Pontifax (Cayman) V L.P.
Pontifax (China) V L.P.
Pontifax 5 G.P. L.P.
Pontifax Management 4 G.P. (2015) Ltd.
Pontifax Late Stage GP Ltd.
Pontifax Late Stage Fund L.P.
Director
10% Owner
250,000$16$4,000,0001,134,671
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-11-29
Exercise
2022-11-30
4:42 pm
N/A
N/A
Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
7,176$0.00011,226,412
(Indirect)
View
2022-11-29
Exercise
2022-11-30
4:42 pm
N/A
2023-10-07
Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
7,176$01,226,412
(Indirect)
View

Ownership(A)
2022-11-30
4:37 pm
N/A
2023-10-07
Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
0$07,176
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
3,545,100$0149,262
(Indirect)
View

Ownership
2020-04-07
8:14 pm
N/A
N/A
Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
0$04,297,008
(Indirect)
View
2019-11-13
Conversion
2019-11-13
7:10 pm
N/A
N/A
89bio Inc.ETNBKariv Tomer
Pontifax (Israel) V L.P.
Pontifax (Cayman) V L.P.
Pontifax (China) V L.P.
Pontifax 5 G.P. L.P.
Pontifax Management 4 G.P. (2015) Ltd.
Pontifax Late Stage GP Ltd.
Pontifax Late Stage Fund L.P.
Director
10% Owner
6,384,672$01,134,671
(Indirect)
View
(A) Indicate amendment filing.